7296 results for "canc*"

in 14.50 milliseconds.

• Rectal Cancer Samples Data Access Committee

  Dac EGAC00001001034

• University of Florida Brain Cancer DAC

  Dac EGAC00001001035

• University Clinic Erlangen/ German Cancer Research Center rare tumors data access committee

  Dac EGAC00001001053

• Age-related remodeling of apparently normal esophageal epithelia by common cancer drivers

  Dac EGAC00001001067

• SNP array datas of "Matched" cancer/PNE

  Dac EGAC00001001069

• DAC for study: Evaluation of commercial Guardant360 ctDNA test in metastatic prostate cancer

  Dac EGAC00001001082

• DAC for Familial Breast Cancer study EGAS00001003305

  Dac EGAC00001001087

• DAC for study Non-coding RNAs in Breast Cancer

  Dac EGAC00001001090

• DAC for study: "Circulating tumour DNA abundance and potential utility in de novo metastatic prostate cancer"

  Dac EGAC00001001099

• DAC for Integrated Genomic, Epigenetic, and Expression Analyses of Ovarian Cancer Cell Lines

  Dac EGAC00001001101

• Radboudumc Cancer Genomics DAC

  Dac EGAC00001001102

• DAC for MCO colorectal cancer genomics at UNSW

  Dac EGAC00001001122

• DAC for Genomic characterization of metastatic breast cancers

  Dac EGAC00001001129

• Korean Advanced Thyroid Cancer Data Access Commitee

  Dac EGAC00001001151

• DAC for GAMuT Project - Peter MacCallum Cancer Centre

  Dac EGAC00001001154

• Leeds Cancer Genomics

  Dac EGAC00001001156

• Children's Cancer Therapy Development Institute Data Access Commitee

  Dac EGAC00001001160

• Stanford Data Access Committee for Multi-Region WES of Metastatic Colorectal Cancer

  Dac EGAC00001001164

• Charbonneau Cancer Institute DAC

  Dac EGAC00001001165

• The data access committee for genome-wide cell-free DNA fragmentation in patients with cancer

  Dac EGAC00001001180

• OSBREAC (Oslo Breast Cancer Research Consortium)

  Dac EGAC00001001186

• Latency and interval therapy affect the evolution in metastatic colorectal cancer.

  Dac EGAC00001001198

• Gastric Cancer Pan-genome Data Access Commitee

  Dac EGAC00001001211

• Immune and Metabolic Features of Brain Metastases Melanoma (Cancer Discovery) Data Access Committee

  Dac EGAC00001001216

• Ewha-Samsumg Lung cancer collaboration DAC

  Dac EGAC00001001237

• DAC for Combined MEK and BCL-2/XL inhibition is effective in high-grade serous ovarian cancer patient-derived xenograft models and BIM levels are predictive of responsiveness

  Dac EGAC00001001250

• UT MD Anderson Cancer Center Genomic Medicine and Leukemia

  Dac EGAC00001001252

• Division of Molecular Oncology, National Cancer Center Research Institute Data Access Committee

  Dac EGAC00001001272

• SMC Colon cancer team

  Dac EGAC00001001277

• DAC for GAMuT Project - Peter MacCallum Cancer Centre

  Dac EGAC00001001278

• Charbonneau Cancer Institute DAC

  Dac EGAC00001001280

• Ewha-Samsung Lung cancer collaboration DAC

  Dac EGAC00001001283

• ASAN Center for Cancer Genome Discovery Data Access Commitee

  Dac EGAC00001001285

• High-grade serous ovarian cancer (MDACC) data access committee

  Dac EGAC00001001288

• DAC for HSTCL study. National Cancer Centre Singapore.

  Dac EGAC00001001302

• DAC for Angiosarcoma Study. National Cancer Centre Singapore.

  Dac EGAC00001001311

• DAC for MEITL study. National Cancer Centre Singapore.

  Dac EGAC00001001323

• The data access committee for Multimodal Genomic Features Predict Outcome of Immune Checkpoint Blockade in Non-small Cell Lung Cancer

  Dac EGAC00001001331

• UCL Cancer Institute Data Access Committee

  Dac EGAC00001001360

• ASAN Center for Cancer Genome Discovery Data Access Commitee

  Dac EGAC00001001391

• Peter MacCallum Cancer Centre Research Data Access Committee

  Dac EGAC00001001404

• The University of Hong Kong Colon Cancer Organoids Genomics Study Data Access Committee

  Dac EGAC00001001405

• Cancer Sequencing Data Access Committee

  Dac EGAC00001001428

• Data access committee for white blood cell and cell-free DNA analyses for detection of residual disease in gastric cancer

  Dac EGAC00001001435

• Cancer Data Access Commitee

  Dac EGAC00001001436

• Yale Cancer Center Data Access Commitee

  Dac EGAC00001001437

• Hyperpolarized 13C MRI in breast cancer DAC

  Dac EGAC00001001438

• Prostate Cancer Biobank Insbruck DAC

  Dac EGAC00001001463

• Metastases of a cancer of unknown primary (CUP)

  Dac EGAC00001001484

• Single Cell RNAseq of blood and tumor from renal cancer patients

  Dac EGAC00001001494